INTERVIEW

JOHN A MERHIGE, CREDENCE MEDSYSTEMS

Credence MedSystems

JOHN A MERHIGE, CREDENCE MEDSYSTEMS

John Merhige discusses Credence’s Companion Safety Syringe System, new advances in the product development pipeline, customer/market driven feedback from user studies and exciting developments planned for 2018 that will take the company on to the next major phase in its growth.

FANNY SELLIER, NEMERA

FANNY SELLIER, NEMERA

Talking here with ONDrugDelivery Magazine, Ms Sellier discusses Nemera’s multidose eyedropper system Novelia® for preservative-free formulations. She explains how this platform has been developed to improve patients’ lives.

NEIL WILLIAMS, MEDICOM INNOVATION PARTNER

NEIL WILLIAMS, MEDICOM INNOVATION PARTNER

In this interview with ONdrugDelivery Magazine, Williams discusses the crucial role connectivity is taking in the drug delivery device industry.

TORSTEN MASCHKE, DATWYLER SEALING SOLUTIONS

Torsten Maschke

TORSTEN MASCHKE, DATWYLER SEALING SOLUTIONS

Torsten Maschke has been Chief Executive of the Sealing Solutions division of Datwyler and a member of the group’s Executive Board since October 2016. Before joining Datwyler Group, he was responsible for the worldwide distribution of sealing and damping solutions for the automotive industry at Freudenberg Group (Weinheim, Germany).

STEVEN R KAUFMAN, BESPAK

STEVEN R KAUFMAN, BESPAK

Steven Kaufman is Global Business Development Lead at Bespak Europe Ltd, responsible for business development activities related to injectable devices such as auto-injectors and wearable injection systems.

GETTING TO KNOW SENSILE MEDICAL

GETTING TO KNOW SENSILE MEDICAL

Chief Executive Officer Derek Brandt and three of his colleagues – Christoph Lüdi, Head of Systems Engineering, Alex Perrier, Senior Technology Manager, and Marco Drüssel, Mechanical Engineering Manager – have all been a part of Sensile Medical for the past ten years, and here reflect on the company’s past and discuss the future.

ARNAUD GUILLET, BIOCORP

ARNAUD GUILLET, BIOCORP

Arnaud Guillet discusses Biocorp’s existing connected devices, value for pharmaceutical partners, accompanying software and data architecture and Biocorp's triple expertise in medical devices, electronics and software.

TONY BRATT, NORDIC PHARMA

TONY BRATT, NORDIC PHARMA

Tony Bratt discusses Nordic Pharma’s specialised market focused business model and how he believes drug delivery systems, in particular the platform device concept, can play an important role in this niche product field.

DIMITRI GRASSWILL, NEMERA

Dimitri Grasswill

DIMITRI GRASSWILL, NEMERA

Dimitri Grasswill speaks with ONdrugDelivery Magazine, in the context of the changing market and technology around inhalation devices.

BILL WELCH, PHILIPS-MEDISIZE

Phillips Medisize

BILL WELCH, PHILIPS-MEDISIZE

Mr Welch gives ONdrugDelivery Magazine an exclusive preview of Phillips-Medisize’s forthcoming workshop, “Realizing the Benefits of Connected Health in Respiratory Drug Delivery”.

MATHIAS ROMACKER, PFIZER

Mathias Romacker

MATHIAS ROMACKER, PFIZER

Mathias Romacker shares his thoughts on the emergence of connectivity in drug delivery devices, he explains why he thinks the buzz around connectivity in delivery systems is more than just hype and describes the trends in the pharma sector that mean it makes sense now to connect up devices.

SIMON MICHEL, CHIEF EXECUTIVE OFFICER, YPSOMED

SIMON MICHEL, CHIEF EXECUTIVE OFFICER, YPSOMED

Simon Michel talks about his vision for how the connected world of drug delivery devices will evolve, and Ypsomed’s central role within it.

JOHN A. MERHIGE, CREDENCE MEDSYSTEMS

Credence MedSystems

JOHN A. MERHIGE, CREDENCE MEDSYSTEMS

John Merhige speaks about Credence’s history, people and devices, and what the company’s core philosophy, “Innovation Without Change” is really about, and how much it genuinely means to Credence.

GETTING TO KNOW ENABLE INJECTIONS

Enable Injections

GETTING TO KNOW ENABLE INJECTIONS

Here follow five mini-interviews with key Enable members. We asked each of them the same five questions, and their answers give interesting insights, from varied perspectives, into what really makes Enable Injections tic.

DR ELIZABETH SHEN, COLORCON

Dr Elizabeth Shen

DR ELIZABETH SHEN, COLORCON

Elizabeth Shen talks taste-masking, from the positive impact on medication adherence, to technical approaches and technology selection, and regulatory considerations.

MIR IMRAN, RANI THERAPEUTICS

MIR IMRAN, RANI THERAPEUTICS

Mir Imran speaks with ONdrugDelivery Magazine in detail about the innovative “Robotic Pill” technology, currently under development by Rani Therapeutics.

JOCHEN RATJEN, SHL GROUP

JOCHEN RATJEN, SHL GROUP

Jochen Ratjen shares his insights when approaching the design and development of user-centric autoinjectors.

INTERVIEW: JEANNIE JOUGHIN, CSL BEHRING

Dr Jeannie Joughin

INTERVIEW: JEANNIE JOUGHIN, CSL BEHRING

Jeannie Joughin speaks exclusively with ONdrugDelivery Magazine about CSL Behring’s agreement with Enable, how it came about, what it means to the two companies, and how it’s going so far.

PATRICK ALEXANDRE, CROSSJECT

Patrick Alexandre

PATRICK ALEXANDRE, CROSSJECT

Shortly after Crossject’s successful IPO on the French NYSE Euronext Paris Exchange (Paris Bourse), Patrick Alexandre spoke about Crossject, its technology and strategy for the future as a publically traded company.

Prev
1
…
3
4
5

Top